Time To Efficacy and Onset Of Action Of Linezolid

Pfizer logo

Pfizer

Status and phase

Completed
Phase 4

Conditions

Skin and Connective Tissue Diseases
Gram-Positive Bacterial Infections

Treatments

Drug: linezolid

Study type

Interventional

Funder types

Industry

Identifiers

NCT00147511
OXAA-0026-162

Details and patient eligibility

About

To assess the onset of action of linezolid

Enrollment

118 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

suspected grampositive infection fever > 38 C

Exclusion criteria

Infections to be treated successfully by surgical procedures

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems